Omega Healthcare Investors OHI Private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4
Private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 at other companies
Other financials
Where this comes from
Reported directly by Omega Healthcare Investors in its filing.
Tagged under the XBRL concept us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss.
The official record: Omega Healthcare Investors’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4?
- Omega Healthcare Investors (OHI) reported private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 of $1.39B in Q1 2026.
- How has Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 changed year-over-year?
- Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 decreased by 1.2% year-over-year, from $1.41B to $1.39B.
- What is the long-term trend for Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4?
- Over 3 years (2022 to 2025), Omega Healthcare Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 has grown at a 9.8% compound annual growth rate (CAGR), from $1.04B to $1.38B.